| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10982567 | Thrombosis Research | 2018 | 15 Pages |
Abstract
- Patient's FV inhibitor was of an IgG class that recognized both the heavy and light chains of FV.
- Patient's FV inhibitor inhibits the FVa-FXa binding, and FV-phospholipid binding.
- In this case, it is thought that the immune response occurred by using fibrin glue 13â¯years ago.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Tomoko Mitsuhashi, Osamu Takamiya,